Assyro AI

Orange Book product · Brand (NDA)

DILAUDID

HYDROMORPHONE HYDROCHLORIDE

Brand (NDA)NDA 019034TE APRX FRESENIUS KABI USA

At a glance

Apr 30, 2009

Approved

Brand (NDA)

Application

AP

TE code

2

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Apr 30, 2009

    17 yr 5 mo ago

  2. Today

  3. Patent 9731082 expires

    Listed drug product patent expiration.

    Apr 23, 2032

    in 5 yr 11 mo

  4. Patent 9248229 expires

    Listed drug product patent expiration.

    Mar 12, 2034

    in 7 yr 10 mo

Pharmaceutical detail

Active ingredient

HYDROMORPHONE HYDROCHLORIDE

Strength

4MG/ML

Dosage form

INJECTABLE

Route

INJECTION

TE code

AP

Application

NDA 019034

Product number

005

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (2)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
9731082Apr 23, 2032in 5 yr 11 mo
Product
9248229Mar 12, 2034in 7 yr 10 mo
Product
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.